ロード中...
Identification of CD4(+) T cell biomarkers for predicting the response of patients with relapsing-remitting multiple sclerosis to natalizumab treatment
Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system of autoimmune etiopathogenesis, and is characterized by various neurological symptoms. Glatiramer acetate and interferon-β are administered as first-line treatments for this disease. In non-responsive patients, s...
保存先:
| 出版年: | Mol Med Rep |
|---|---|
| 主要な著者: | , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
D.A. Spandidos
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6580020/ https://ncbi.nlm.nih.gov/pubmed/31180553 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mmr.2019.10283 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|